-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Quince Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2021 to Q3 2024.
- Quince Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $13K.
- Quince Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $525K.
- Quince Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $197K.
- Quince Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$284K.
- Quince Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)